Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Nanotech firms encountering mega-doubts

April 17th, 2006

Nanotech firms encountering mega-doubts

Abstract:
NanoPore Inc., a company formed in 1993 to develop nanotechnology-based products for the pharmaceutical, aerospace and other industries, is looking to open another manufacturing facility in Albuquerque and create 15 new jobs by the end of July. Now if it could just find more believers with faith that nanotechnology is an industry worthy of attention in Albuquerque.

Source:
ACBJ

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

NanoPore

Related News Press

Jobs

Could quantum technology be New Mexico’s next economic boon? Quantum New Mexico Coalition aims to establish state as national hub April 1st, 2022

SEMI Partners with GLOBALFOUNDRIES to Offer Apprenticeship Program Aimed at Building the Electronics Talent Pipeline August 11th, 2020

March 17th, 2020

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 29th, 2019

Nanomedicine

New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024

Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Profiles

Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011

Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011

Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010

Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project